Published in Cancer Weekly, August 11th, 2009
"We performed a collaborative prospective safety study with Okayama University to introduce TC therapy. The subjects were 53 patients aged from 33 to 67 years at intermediate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.